Quotes Madrigal Pharmaceuticals, Inc. Deutsche Boerse AG
Stocks
YDO1
US5588681057
Biotechnology & Medical Research
|
Real-time Estimate
Tradegate
10:53:22 2026-10-01 EDT
|
5-day change | 1st Jan Change | ||
| 446.55 EUR | +0.51% |
|
-1.56% | -10.56% |
| 09-24 | Analyst recommendations: Dropbox, Etsy, Meta Platforms, Okta, Rollins… |  |
| 09-23 | Citigroup Initiates Madrigal Pharmaceuticals at Buy With $725 Price Target | MT |
Stock exchange
Deutsche Boerse AG
YDO1 442.90 €
-0.32%
0
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| MDGL | 502.40USD | -0.31% | 7.81M $ | ||
CBOE
| MDGL | 503.57USD | -2.33% | 4.44M $ | |
|
Tradegate
| YDO1 | 448.20EUR | +0.81% | 448.2 € | |
|
Deutsche Boerse AG
| YDO1 | 442.90EUR | -0.32% | 0 € | |
|
Börse Stuttgart
| YDO1 | 443.40EUR | -0.18% | 0 € | |
|
Boerse Muenchen
| YDO1 | 446.30EUR | -0.02% | 0 € | |
|
Borsa Italiana
| 1MDGL | 448.90EUR | +0.09% | 0 € | |
|
Xetra
| YDO1 | 447.10EUR | -0.42% | 0 € |
Quotes 5-day view: Madrigal Pharmaceuticals, Inc.
Delayed Quote Deutsche Boerse AG
| 2026-09-25 | 2026-09-28 | 2026-09-29 | 2026-09-30 | 2026-10-01 | |
|---|---|---|---|---|---|
| Last | €450.50 | €452.90 | €445.30 | €444.30 | €442.90 |
| Volume | 3 | 0 | 5 | 0 | 0 |
| Change | +0.13% | +0.53% | -1.68% | -0.22% | +0.51% |
| Opening | €447.30 | €448.00 | €450.20 | €446.00 | €442.10 |
| High | €456.40 | €455.10 | €451.60 | €451.50 | €442.90 |
| Low | €447.00 | €445.80 | €445.30 | €444.30 | €442.10 |
Performance
| 1 day | +0.54% | ||
| 1 week | -1.56% | ||
| Current month | -0.32% | ||
| 1 month | -4.07% | ||
| 3 months | -2.01% | ||
| 6 months | -2.53% | ||
| Current year | -10.56% | ||
| 1 year | +15.49% | ||
| 3 years | +227.10% | ||
| 5 years | +551.32% | ||
| 10 years | +3,437.54% |
Volumes
marketsDaily volume
0
Estimated daily volume
0
Avg. Volume 20 sessions
14
Daily volume ratio
0
Avg. Volume 20 sessions
6,251.7
Avg. Volume 20 sessions USD
7,055.29
Record volume 1
2,000
Record volume 2
1,025
Record volume 3
853
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (EUR)
11,643,555,338
Market Cap (USD)
11,643,555,338
Net sales (USD)
958,403,000
Number of employees
915
Sales / Employee (USD)
1,047,435
Free-Float
94.17%
Free-Float capitalization (EUR)
12,451,863,251
Free-Float capitalization (USD)
10,965,110,779
Average Daily Capital Traded
-.--%
Indicators
Moving average 5 days
448.58
Moving average 20 days
458.3
Moving average 50 days
454.63
Moving average 100 days
450.23
Price spread / (MMA5)
+0.45%
Price spread / (MMA20)
+2.63%
Price spread / (MMA50)
+1.81%
Price spread / (MMA100)
+0.82%
RSI 9 days
38.5
RSI 14 days
43.36
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.51% | -1.56% | +15.49% | +227.10% | 11.64B | |
| +4.16% | -0.36% | +49.37% | +94.17% | 74.46B | |
| -0.68% | +1.03% | +27.52% | +80.60% | 60.14B | |
| -2.47% | -1.51% | +5.01% | +33.51% | 48.15B | |
| -1.62% | -3.67% | +30.00% | +36.64% | 44.25B | |
| +2.27% | +5.14% | +358.22% | +702.98% | 43.99B | |
| -0.63% | +0.90% | +8.37% | +103.47% | 41.61B | |
| -0.67% | +0.17% | +7.60% | +46.37% | 29.97B | |
| +4.77% | +6.16% | +36.77% | +22.78% | 29.31B | |
| -2.64% | -8.43% | -24.43% | +338.71% | 24.93B | |
| Average | +0.32% | +1.53% | +51.39% | +168.63% | 40.84B | |
| Weighted average by Cap. | +0.55% | +1.53% | +58.48% | +155.40% |
Historical Quotes: Madrigal Pharmaceuticals, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 1 week | 442.1 |  | 456.4 |
| 1 month | 442.1 | | 471.9 |
| Current year | 354 | | 506.4 |
| 1 year | 347.5 | | 523.2 |
| 3 years | 112.6 | | 523.2 |
| 5 years | 47 | | 523.2 |
| 10 years | 11.31 | | 523.2 |
Monthly variations
Annual variations
| 2026 | -10.28% | ||
| 2025 | +66.79% | ||
| 2024 | +42.47% | ||
| 2023 | -24.49% | ||
| 2022 | +280.69% | ||
| 2021 | -17.67% | ||
| 2020 | +6.84% | ||
| 2019 | -8.11% | ||
| 2018 | +15.57% | ||
| 2017 | +441.13% | ||
| 2016 | +5,395.02% |
- Stock Market
- Stocks
- MDGL Stock
- YDO1 Stock
- Quotes Madrigal Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
